Western Wealth Management LLC Sells 1,332 Shares of Intuitive Surgical, Inc. $ISRG

Western Wealth Management LLC decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 15.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,515 shares of the medical equipment provider’s stock after selling 1,332 shares during the period. Western Wealth Management LLC’s holdings in Intuitive Surgical were worth $3,056,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in ISRG. Dogwood Wealth Management LLC raised its holdings in shares of Intuitive Surgical by 178.3% in the 3rd quarter. Dogwood Wealth Management LLC now owns 64 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 41 shares in the last quarter. North Point Portfolio Managers Corp OH acquired a new stake in Intuitive Surgical during the third quarter valued at approximately $27,000. John Boyer Inc. bought a new stake in Intuitive Surgical during the third quarter worth approximately $27,000. Compass Wealth Management LLC bought a new stake in Intuitive Surgical during the third quarter worth approximately $29,000. Finally, Compass Financial Management LLC bought a new stake in Intuitive Surgical during the second quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent research reports. Royal Bank Of Canada decreased their price target on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 21st. Oppenheimer reiterated an “outperform” rating and set a $500.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 21st. TD Cowen reissued a “buy” rating and set a $485.00 price objective on shares of Intuitive Surgical in a research note on Monday, October 19th. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research note on Thursday. Finally, Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $493.54.

Get Our Latest Report on Intuitive Surgical

Insider Buying and Selling

In other news, Director Gary Guthart sold 10,000 shares of the stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $457.34, for a total transaction of $4,573,400.00. Following the transaction, the director owned 1,194,530 shares in the company, valued at $546,306,350.20. This represents a 0.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total transaction of $183,260.00. Following the transaction, the executive vice president owned 6,236 shares in the company, valued at $2,857,023.40. This represents a 6.03% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 39,379 shares of company stock valued at $17,739,043. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $437.75 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The company has a market capitalization of $151.74 billion, a PE ratio of 52.93, a PEG ratio of 3.03 and a beta of 1.45. The company’s 50 day moving average price is $419.01 and its 200 day moving average price is $429.55.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period last year, the business earned $2.40 EPS. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

About Intuitive Surgical

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.